|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of long-lived assets | |||||
| Impairment of goodwill | |||||
| Impairment of intangible assets | |||||
| Impairment of operating lease right-of-use assets | |||||
| Unrealized gain on marketable securities | |||||
| Foreign currency remeasurement loss | |||||
| Gain on lease termination | |||||
| Issuance of shares of Common Stock for services | |||||
| Loss on disposal of assets, net | |||||
| Amortization of operating lease right of use asset | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| (Gain) loss on equity investment | |||||
| Change in fair value of derivative liability | |||||
| Change in fair value of warrant liability | |||||
| Loss on issuance of Series G Preferred Stock | |||||
| Changes in assets and liabilities: | |||||
| (Increase) decrease in inventory | |||||
| (Increase) decrease in accounts receivable | |||||
| Decrease (increase) in deferred revenue | |||||
| (Decrease) increase in deferred revenue | |||||
| (Increase) in other assets, current and non-current | |||||
| (Decrease) in other liabilities, current and non-current | |||||
| Increase in accounts payable | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of property and equipment | |||||
| Investment in marketable securities | |||||
| Sale of marketable securities | |||||
| Acquisition of Naples Wax net of cash assumed | |||||
| Naples Wax LLC | |||||
| Total acquisition of Naples Wax net of cash assumed | |||||
| Acquisition of intangibles | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Contributions from noncontrolling interests | |||||
| Stock option exercised | |||||
| Payments for shares withheld on vesting | |||||
| Proceeds from registered offering, net of offering costs | |||||
| Redemption of preferred stock | |||||
| Distributions to noncontrolling interests | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of the year | |||||
| Cash, cash equivalents, and restricted cash at end of the period | |||||
| Cash paid for | |||||
| Income taxes | |||||
| Non-cash investing and financing transactions | |||||
| Issuance of shares of Common Stock for legal settlement | |||||
| Right-of-use assets obtained in exchange for operating lease obligations | |||||
| Capital expenditures included in Accounts payable, accrued expenses and other current liabilities | |||||
| Accrual of Series convertible preferred stock dividends | |||||
| Accretion of Series G convertible preferred stock to redemption value | |||||
| Initial fair value of warrant liability | |||||
| Initial fair value of derivative liability | |||||
| Accrued Series G convertible preferred stock redemption payable | |||||
| Noncash conversion of Series G convertible preferred stock | |||||
| Deemed dividend on Exchange of Series G Preferred Stock | |||||
| Deemed dividend on warrant exchange | |||||
| Initial fair value of derivative liability on convertible debt | |||||
| Extinguishment of convertible preferred stock with bifurcated embedded derivative | |||||
| Fair value of convertible note on exchange | |||||
| Reclass of warrant liability upon modification | |||||
| Lease liability remeasurement due to modification | |||||
| Right-of-use asset and lease liability recognized for new operating lease | |||||
Loading...